$123.96
+0.02 (+0.02%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+52.89%
YTD
+22.93%
Open$123.97
Previous Close$123.94
Day High$123.99
Day Low$123.95
52W High$123.99
52W Low$75.20
Volume—
Avg Volume1.79M
Market Cap9.79B
P/E Ratio—
EPS$-6.05
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$103.76
Above
SMA 200
$88.57
Above
RSI (14)
53.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
23 analysts
Price Target
-73.2% upside
Current
$123.96
$123.96
Target
$33.28
$33.28
$20.12
$33.28 avg
$44.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.56B | 1.45B | 1.21B |
| Net Income | -302,764,100 | -377,638,036 | -264,320,064 |
| Profit Margin | -19.4% | -26.0% | -21.8% |
| EBITDA | -533,448,597 | -500,050,490 | -459,692,337 |
| Free Cash Flow | -391,442,676 | -279,670,611 | -274,115,194 |
| Rev Growth | +10.6% | +5.5% | +20.0% |
| Debt/Equity | 0.68 | 0.65 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |